ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Author Response to "Interpreting romosozumab for cancer treatment-induced bone loss: measurement, missing data, and surveillance".

Hirotaka Koyanagi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.